Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PureTech Health plc - American Depositary Shares (NQ:PRTC)

18.18 +0.18 (+1.00%)
Streaming Delayed Price Updated: 3:22 PM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PureTech Health plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
PureTech Founded Entity Vedanta Biosciences Announces New Data from Phase 1 Study of VE202 for the Treatment of Inflammatory Bowel Disease
From PureTech Health plc
Via Business Wire
Vedanta Biosciences Presents New Data from Phase 1 Study of VE202, Its Rationally-Defined Consortium for the Treatment of Inflammatory Bowel Disease, at the International Human Microbiome Consortium Congress 2021 (IHMC)
From Vedanta Biosciences
Via Business Wire
PureTech Founded Entity Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers
From PureTech Health plc
Via Business Wire
PureTech Adds Inflammatory Disease Candidates To Pipeline With Alivio Buyout
Four years after launching Alivio Therapeutics, PureTech Health plc (NASDAQ: PRTC) is bringing the hydrogel player back into the fold by acquiring the... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Orphazyme (NASDAQ:ORPH) shares moved upwards by 72.49% to $17.34 during Wednesday's regular session. As of 12:31 EST, Orphazyme's stock is trading at a... 
Via Benzinga
PureTech Acquires Remaining Interest in Founded Entity Alivio Therapeutics
From PureTech Health plc
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Kindred Biosciences (NASDAQ:KIN) shares increased by 24.08% to $6.75 during Thursday's regular session. Kindred Biosciences's stock is trading at a volume... 
Via Benzinga
Results of Annual General Meeting
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Gelesis Presents Findings on Plenity®-Induced Weight Loss at the American Association of Clinical Endocrinology (AACE) 2021 Annual Virtual Meeting
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital Therapeutics
From PureTech Health plc
Via Business Wire
PureTech to Present at the Jefferies Virtual Healthcare Conference
From PureTech Health plc
Via Business Wire
PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders
From PureTech Health plc
Via Business Wire
PureTech Announces Nature Publication Supporting Modulation of Meningeal Lymphatics to Target Alzheimer’s Disease Pathologies
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Gelesis Appoints Procter & Gamble Veteran Jane Wildman to Board of Directors
From PureTech Health plc
Via Business Wire
Vedanta Biosciences to Present at the 2021 Jefferies Virtual Microbiome-Based Therapeutics Summit
From Vedanta Biosciences
Via Business Wire
Earnings Scheduled For April 15, 2021
Companies Reporting Before The Bell • Charles Schwab (NYSE:SCHW) is projected to report quarterly earnings at $0.82 per share on revenue of $4.58 billion. •... 
Via Benzinga
PureTech Announces Annual Results for Year Ended December 31, 2020
From PureTech Health plc
Via Business Wire
PureTech Presents Promising Preclinical Data from LYT-210 Immuno-Oncology Program at American Association for Cancer Research (AACR) Annual Meeting
From PureTech Health plc
Via Business Wire
PureTech to Present at Two Upcoming Investor Conferences
From PureTech Health plc
Via Business Wire
Stocks That Hit 52-Week Highs On Thursday
Thursday morning saw 168 companies set new 52-week highs. Intriguing Points: Microsoft (NASDAQ:MSFT) was the largest company by market cap to set a new 52-week high... 
Via Benzinga
PureTech Founded Entity Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Potential Treatment for Patients with COVID Brain Fog
From PureTech Health plc
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.